Managing pertussis outbreaks Aside from the difference in antigens, though, scientists remain unsure what made the whole -
cell vaccine so effective.
Not exact matches
The
so - called STEP trial, sponsored by pharmaceutical giant Merck & Co. and the federally funded HIV
Vaccine Trials Network (HVTN), was the first to test the idea of stimulating the immune system's killer T
cells to hunt for the virus more aggressively, in this case using a weakened form of the cold virus to carry three genes from HIV.
One difficulty is that everyone's dendritic
cells are different,
so vaccines need to be personalized, making them expensive and labor - intensive to produce.
Then you activate the killer T
cells with the dendritic -
cell vaccine,
so now you've got all your smart bombs and your cruise missiles coming in from outside.
A pancreatic cancer
vaccine could be made of whole pancreatic cancer
cells, treated
so they can't replicate, but modified to present certain molecules on the surface of those
cells.
The
vaccine, which is about to go on trial in the US, aims to re-educate T
cells so that they no longer react to the dander.
In the 30 years since scientists identified HIV as the cause of AIDS, the virus has proved unbeatable — hiding in the very immune
cells that would kill it; reflexively and rapidly mutating; mysteriously persisting in the gut, kidneys, liver, and brain; subverting every
vaccine (the best one
so far has given only 30 percent protection); and roaring back to life almost the moment drugs are stopped.
The new technique, pioneered by Wilson and fellow researchers at the Emory University School of Medicine in Atlanta, saves time by using antibodies produced by
so - called B
cells (white blood
cells that produce and then ferry them to infection sites to battle invading germs) in response to
vaccines instead of to actual infections.
Learning what they contribute to
cell structure, permeability, membrane biogenesis and
so on is important in
vaccine research because antibodies against protein antigens can disable the protein's function.»
«The parasite infects a new
cell within about 15 seconds,
so a
vaccine to prevent that action would have to work immediately,» he says.
So if you received a
vaccine for varicella, for instance, you will have T
cells that will protect you for life against chickenpox.
Vaccines work by priming our immune systems - including antibodies and T -
cells -
so that they will be ready for action if a bug comes along.
Earlier versions of such
vaccines largely failed because they targeted single invading substances that were not mutated,
so T
cells that attack invaders often ignored them, he says.
Once taken up by antigen - presenting
cells, which help focus the immune system on an invader, the
vaccine releases a factor that heightens their attention specifically to the cancer - promoting protein E7, a
so - called oncoprotein that not only enables the human papillomavirus to multiply, but potentially cervical cancer
cells to do the same.
The development of a standardized method to express large panels of P. falciparum
cell surface and secreted proteins in their native conformation would enable comprehensive protein libraries to be systematically screened in parallel
so that direct comparisons between antigens can be made in functional assays such as
vaccine screening and immuno - epidemiology studies.
If antibodies from colostrum are still circulating within your puppy's bloodstream, the
vaccine is immediately neutralized
so your puppy's
cells do not learn how to fight the infection.